MX2011011190A - Metodos para tratar una infeccion bacteriana pulmonar utilizando fluoro-quinolonas. - Google Patents
Metodos para tratar una infeccion bacteriana pulmonar utilizando fluoro-quinolonas.Info
- Publication number
- MX2011011190A MX2011011190A MX2011011190A MX2011011190A MX2011011190A MX 2011011190 A MX2011011190 A MX 2011011190A MX 2011011190 A MX2011011190 A MX 2011011190A MX 2011011190 A MX2011011190 A MX 2011011190A MX 2011011190 A MX2011011190 A MX 2011011190A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- treating
- bacterial infection
- quinolones
- fluoro
- Prior art date
Links
- 208000035143 Bacterial infection Diseases 0.000 title abstract 2
- 208000022362 bacterial infectious disease Diseases 0.000 title abstract 2
- 230000002685 pulmonary effect Effects 0.000 title abstract 2
- FRFSUUWVTVDAJG-UHFFFAOYSA-N 3-fluoro-1h-quinolin-2-one Chemical class C1=CC=C2NC(=O)C(F)=CC2=C1 FRFSUUWVTVDAJG-UHFFFAOYSA-N 0.000 title 1
- 229940124307 fluoroquinolone Drugs 0.000 title 1
- 241000894006 Bacteria Species 0.000 abstract 4
- 239000003306 quinoline derived antiinfective agent Substances 0.000 abstract 3
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 abstract 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229960003376 levofloxacin Drugs 0.000 abstract 1
- 229960001699 ofloxacin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Se describen en la presente métodos para tratar una infección bacteriana pulmonar que comprende el desarrollo de bacterias bajo condiciones anaeróbicas utilizando un antibiótico de fluoroquinolona. El antibiótico de fluoroquinolona puede por ejemplo, ser levofloxacina o ofloxacina. También se describen métodos para inhibir el desarrollo de bacterias bajo condiciones anaeróbicas al exponer las bacterias a una cantidad de antibiótico de fluoroquinolona efectiva para inhibir el desarrollo de dichas bacterias.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17262509P | 2009-04-24 | 2009-04-24 | |
| PCT/US2010/032128 WO2010124141A1 (en) | 2009-04-24 | 2010-04-22 | Methods of treating a pulmonary bacterial infection using fluoro-quinolones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2011011190A true MX2011011190A (es) | 2012-02-13 |
| MX339077B MX339077B (es) | 2016-05-10 |
Family
ID=43011488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011011190A MX339077B (es) | 2009-04-24 | 2010-04-22 | Metodos para tratar una infeccion bacteriana pulmonar utilizando fluoro-quinolonas. |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US20120035166A1 (es) |
| EP (1) | EP2421539B1 (es) |
| JP (2) | JP6179844B2 (es) |
| KR (1) | KR20120034626A (es) |
| CN (2) | CN107050032A (es) |
| AU (1) | AU2010238765B2 (es) |
| BR (1) | BRPI1006626B8 (es) |
| CA (1) | CA2759874C (es) |
| CL (1) | CL2011002649A1 (es) |
| CO (1) | CO6450642A2 (es) |
| CY (1) | CY1122525T1 (es) |
| DK (1) | DK2421539T3 (es) |
| ES (1) | ES2755754T3 (es) |
| HR (1) | HRP20191951T1 (es) |
| HU (1) | HUE046595T2 (es) |
| IL (1) | IL215777A (es) |
| LT (1) | LT2421539T (es) |
| MX (1) | MX339077B (es) |
| MY (1) | MY178871A (es) |
| NZ (1) | NZ596245A (es) |
| PL (1) | PL2421539T3 (es) |
| PT (1) | PT2421539T (es) |
| RU (1) | RU2535056C2 (es) |
| SG (3) | SG10201811494SA (es) |
| SI (1) | SI2421539T1 (es) |
| SM (1) | SMT201900645T1 (es) |
| WO (1) | WO2010124141A1 (es) |
| ZA (1) | ZA201107903B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8546423B2 (en) | 2005-05-18 | 2013-10-01 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
| CN102202649A (zh) | 2008-10-07 | 2011-09-28 | Mpex医药有限公司 | 用于改进的药物动力学的氟喹诺酮气雾剂制剂 |
| PL2346509T3 (pl) | 2008-10-07 | 2021-03-08 | Horizon Orphan Llc | Lewofloksacyna w postaci aerozolu dla zmniejszania stanu zapalnego płuc |
| KR20120100904A (ko) | 2009-09-04 | 2012-09-12 | 엠펙스 파마슈티컬즈, 인코포레이티드 | 낭포성 섬유증을 치료하기 위한 에어로졸화된 레보플록사신의 용도 |
| US9572774B2 (en) | 2011-05-19 | 2017-02-21 | Savara Inc. | Dry powder vancomycin compositions and associated methods |
| EP2968801B1 (en) * | 2013-03-14 | 2018-09-26 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| JP6966835B2 (ja) * | 2016-02-05 | 2021-11-17 | ホライズン オーファン リミテッド ライアビリティ カンパニー | 嚢胞性線維症のためのフルオロキノロン製剤 |
| CN108849939B (zh) * | 2018-07-31 | 2021-02-19 | 广东省农业科学院植物保护研究所 | 盐酸左氧氟沙星在制备用于防治烟草青枯病的农药制剂中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003230600B2 (en) | 2002-03-05 | 2009-06-04 | Transave, Inc. | An inhalation system for prevention and treatment of intracellular infections |
| RU2255757C1 (ru) * | 2004-06-22 | 2005-07-10 | Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" | Пептидное соединение, восстанавливающее функцию органов дыхания |
| EP1901749B1 (en) * | 2005-05-18 | 2016-08-03 | Raptor Pharmaceuticals Inc. | Aerosolized fluoroquinolones and uses thereof |
| US7838532B2 (en) | 2005-05-18 | 2010-11-23 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
| CA2724009C (en) * | 2008-05-15 | 2016-10-11 | Novartis Ag | Pulmonary delivery of a fluoroquinolone |
| CN102202649A (zh) * | 2008-10-07 | 2011-09-28 | Mpex医药有限公司 | 用于改进的药物动力学的氟喹诺酮气雾剂制剂 |
-
2010
- 2010-04-22 SG SG10201811494SA patent/SG10201811494SA/en unknown
- 2010-04-22 KR KR1020117027809A patent/KR20120034626A/ko not_active Ceased
- 2010-04-22 DK DK10767800T patent/DK2421539T3/da active
- 2010-04-22 SM SM20190645T patent/SMT201900645T1/it unknown
- 2010-04-22 JP JP2012507400A patent/JP6179844B2/ja active Active
- 2010-04-22 RU RU2011145430/15A patent/RU2535056C2/ru active
- 2010-04-22 MX MX2011011190A patent/MX339077B/es active IP Right Grant
- 2010-04-22 BR BRPI1006626A patent/BRPI1006626B8/pt active IP Right Grant
- 2010-04-22 AU AU2010238765A patent/AU2010238765B2/en active Active
- 2010-04-22 SG SG10201403512TA patent/SG10201403512TA/en unknown
- 2010-04-22 MY MYPI2011005063A patent/MY178871A/en unknown
- 2010-04-22 ES ES10767800T patent/ES2755754T3/es active Active
- 2010-04-22 NZ NZ596245A patent/NZ596245A/xx unknown
- 2010-04-22 EP EP10767800.5A patent/EP2421539B1/en active Active
- 2010-04-22 SG SG2011076932A patent/SG175288A1/en unknown
- 2010-04-22 CN CN201610900988.6A patent/CN107050032A/zh active Pending
- 2010-04-22 LT LT10767800T patent/LT2421539T/lt unknown
- 2010-04-22 SI SI201031951T patent/SI2421539T1/sl unknown
- 2010-04-22 WO PCT/US2010/032128 patent/WO2010124141A1/en not_active Ceased
- 2010-04-22 PT PT107678005T patent/PT2421539T/pt unknown
- 2010-04-22 HR HRP20191951TT patent/HRP20191951T1/hr unknown
- 2010-04-22 PL PL10767800T patent/PL2421539T3/pl unknown
- 2010-04-22 CN CN2010800180220A patent/CN102427815A/zh active Pending
- 2010-04-22 CA CA2759874A patent/CA2759874C/en active Active
- 2010-04-22 HU HUE10767800A patent/HUE046595T2/hu unknown
-
2011
- 2011-10-21 US US13/278,706 patent/US20120035166A1/en not_active Abandoned
- 2011-10-23 IL IL215777A patent/IL215777A/en active IP Right Grant
- 2011-10-24 CL CL2011002649A patent/CL2011002649A1/es unknown
- 2011-10-29 ZA ZA2011/07903A patent/ZA201107903B/en unknown
- 2011-11-02 CO CO11148624A patent/CO6450642A2/es not_active Application Discontinuation
-
2015
- 2015-10-09 JP JP2015201285A patent/JP6228580B2/ja not_active Expired - Fee Related
-
2019
- 2019-11-06 CY CY20191101155T patent/CY1122525T1/el unknown
-
2020
- 2020-02-20 US US16/796,525 patent/US20210015811A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY178871A (en) | Methods of treating a pulmonary bacterial infection using fluoro-quinolones | |
| MY174523A (en) | ?-lactamase inhibitor and process for preparing the same | |
| EP3409666A3 (en) | Seca inhibitors and methods of making and using thereof | |
| WO2012135016A3 (en) | Inhibition of bacterial biofilms and microbial growth with imidazole derivatives | |
| NZ593111A (en) | Antibacterial compounds | |
| WO2018208985A3 (en) | Antibacterial compounds | |
| MX358682B (es) | Derivados de pirazolo [1,5a]pirimidina y de tieno[3,2b] pirimidina como moduladores de la cinasa asociada al receptor de la interleucina 4 (irak4). | |
| MX366793B (es) | Metodos para preparar oxazolidinonas y composiciones que las contienen. | |
| NZ708928A (en) | Mannose derivatives for treating bacterial infections | |
| EP2408294A4 (en) | SYSTEM AND METHOD FOR THE TREATMENT OF WASTEWATER BY BREEDING PHOTOTAKTIC HETEROTROPHIC MICROORGANISMS | |
| SG178952A1 (en) | Chemical compounds | |
| CA2710814C (en) | Bacterial ghost (bg) production process using betapropiolactone (blp) for final inactivation | |
| MX2013008162A (es) | Inhibidores de pirimidina y topoisomerasa iv. | |
| WO2012103295A3 (en) | Small molecule rnase inhibitors and methods of use | |
| IL287931A (en) | Bioreactors for the growth of microorganisms | |
| MX2021001564A (es) | Diazabiciclooctanonas como inhibidores de serina beta-lactamasas. | |
| WO2014022382A3 (en) | Antibacterial protein kinase inhibitors | |
| IN2012DN03846A (es) | ||
| IL284678A (en) | Bioreactors for growing micro-organisms | |
| PH12013501293A1 (en) | Use of nitrogen-free peroxygen-releasing compound to reduce growth of contaminant microorganisms in ethanol fermentation | |
| EA201170121A1 (ru) | Лечение инфекций, вызванных антибиотикоустойчивыми бактериями | |
| NZ713357A (en) | Antimicrobial compounds and methods of making and using the same | |
| MY156304A (en) | 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases | |
| WO2012085255A3 (en) | Volatile organic compounds from bacterial antagonists for controlling microbial growth | |
| WO2011076912A3 (en) | Methods and compositions for biologically controlling microbial growth on clean room equipment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |